Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

BioMarin Pharma Offers $680M for Prosensa

By Pharmaceutical Processing | November 24, 2014

SAN RAFAEL, Calif. (AP) — BioMarin Pharmaceutical will pay $680 million in cash for the Dutch biotech company Prosensa in a bid to strengthen its pipeline of genetic disorder treatments.

The San Rafael, California, company also said it will make two approximately $80 million milestone payments to Prosensa shareholders if U.S. and European regulators approve the Duchenne muscular dystrophy treatment, drisapersen.

Duchenne muscular dystrophy is a fatal genetic disease that causes increasing muscle weakness and affects one of every 3,500 boys born worldwide.

BioMarin said Monday that it will pay $17.75 for each share of the drug developer, not counting the milestone payments. That represents a 55 percent premium to the U.S.-traded stock’s closing price of $11.44 on Friday.

Shares of Prosensa Holding NV soared above BioMarin’s offer price after the deal was announced, a possible sign that investors expect a higher bid. The stock rose nearly 62 percent, or $7.06, to $18.50 hours before U.S. markets opened Monday. Shares have more than doubled in price so far this year.

Shares of BioMarin Pharmaceutical Inc. have climbed 22 percent this year as of Friday’s close at $85.83.

Related Articles Read More >

This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
PHARMAP 2025: Pharma leaders converge in Berlin for fifth anniversary summit
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE